Presented at the 2012 AAPM Annual Meeting « Back

Use of a Newly Developed Delivery Device for Percutaneous Introduction of Multiple Configurations of Spinal Cord Stimulation Leads

Matthew Schocket, MD, drschocket@capitolpain.com¹, Louis J. Raso, MD PA², Timothy R. Deer, MD³ (1) Capitol Pain Institute, Austin, Texas, (2) Solo Practice, Jupiter, Florida, (3) The Center for Pain Relief, Charleston, West Virginia

Introduction: The novel Epiducer™ lead delivery system is used to percutaneously implant an S-series™ paddle lead (both St. Jude Medical Neuromodulation Division, Plano, TX) or multiple percutaneous leads with only one needle stick. Results from an observational data collection study assessing the frequency of placement of different lead configurations using the Epiducer system are presented. Methods: An IRB-approved observational data collection study evaluated use patterns pertaining to the Epiducer system. In addition to the number and frequency of different lead configurations, the following procedural aspects of the surgery were recorded during the evaluation: procedure time, angle of entry, distance from entry to final lead placement, and physician feedback. Results: Data will be collected from 25 investigational sites. Preliminary data from 14 trial and permanent cases at one site revealed that 14.3% of cases were implanted with a percutaneous lead and an S-series lead, 14.3% with a single percutaneous lead, 21.4% with two percutaneous leads, and an S-series lead and 50% with dual percutaneous leads. In 100% of the cases, the physician rated his use of the Epiducer lead delivery system, his ability to implant an S-series paddle lead through the Epiducer system, and his ability to place multiple lead arrays through the system as satisfied/very satisfied. Conclusion: Preliminary data indicates the Epiducer™ lead delivery system allows for successful implantation of a paddle lead or multiple percutaneous leads.

Funding: This work was supported by St. Jude Medical Neuromodulation Division through a sponsored clinical research study. Drs. Schocket, Raso, and Deer are paid consultants of St. Jude Medical Neuromodulation Division.